Variant report
Variant | nsv978484 |
---|---|
Chromosome Location | chr17:20487936-20489527 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:5)
- CpG islands (count:61)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:5 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | EP300 | chr17:20487434-20488099 | SK-N-SH | brain: | n/a | n/a |
2 | MXI1 | chr17:20487446-20488080 | SK-N-SH | brain: | n/a | n/a |
3 | POLR2A | chr17:20488314-20488577 | GM12878 | blood: | n/a | n/a |
4 | POLR2A | chr17:20488077-20488117 | H1-hESC | embryonic stem cell: | n/a | n/a |
5 | REST | chr17:20487185-20487972 | SK-N-SH | brain: | n/a | n/a |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr17:20489071-20489121 | HepG2 | liver: | n/a |
2 | chr17:20489071-20489121 | SK-N-MC | brain: | n/a |
3 | chr17:20489071-20489121 | NH-A | brain: | n/a |
4 | chr17:20489071-20489121 | AG04450 | lung: | fetal |
5 | chr17:20489071-20489121 | HNPCEpiC | eye: | n/a |
6 | chr17:20489071-20489121 | Caco-2 | colon: | n/a |
7 | chr17:20489071-20489121 | HL-60 | blood: | n/a |
8 | chr17:20489071-20489121 | GM12891 | blood: | n/a |
9 | chr17:20489071-20489121 | ovcar-3 | ovarian: | n/a |
10 | chr17:20489071-20489121 | LNCaP | prostate: | n/a |
11 | chr17:20489071-20489121 | NB4 | blood: | n/a |
12 | chr17:20489071-20489121 | AG04449 | skin: | fetal |
13 | chr17:20489071-20489121 | NT2-D1 | testis: | n/a |
14 | chr17:20489071-20489121 | HCPEpiC | choroid plexus: | n/a |
15 | chr17:20489071-20489121 | HIPEpiC | eye: | n/a |
16 | chr17:20489071-20489121 | RPTEC | kidney: | n/a |
17 | chr17:20489071-20489121 | HCT-116 | colon: | n/a |
18 | chr17:20489071-20489121 | GM06990 | blood: | n/a |
19 | chr17:20489071-20489121 | SK-N-SH_RA | brain: | n/a |
20 | chr17:20489071-20489121 | HRE | kidney: | n/a |
21 | chr17:20489071-20489121 | PANC-1 | pancreas: | n/a |
22 | chr17:20489071-20489121 | T-47D | breast: | n/a |
23 | chr17:20489071-20489121 | HPAEpiC | pulmonary alveolar: | n/a |
24 | chr17:20489071-20489121 | SAEC | small airway: | n/a |
25 | chr17:20489071-20489121 | NHBE | bronchial: | n/a |
26 | chr17:20489071-20489121 | AG10803 | skin: | n/a |
27 | chr17:20489071-20489121 | AoSMC | blood vessel: | n/a |
28 | chr17:20489071-20489121 | GM12878 | blood: | n/a |
29 | chr17:20489071-20489121 | Hela-S3 | cervix: | n/a |
30 | chr17:20489071-20489121 | CMK | blood: | n/a |
31 | chr17:20489071-20489121 | MCF-7 | breast: | n/a |
32 | chr17:20489071-20489121 | HUVEC | blood vessel: | n/a |
33 | chr17:20489071-20489121 | NHDF-neo | bronchial: | n/a |
34 | chr17:20489071-20489121 | Hepatocyte | liver: | n/a |
35 | chr17:20489071-20489121 | IMR90 | lung: | fetal |
36 | chr17:20489071-20489121 | SKMC | muscle: | n/a |
37 | chr17:20489071-20489121 | K562 | blood: | n/a |
38 | chr17:20489071-20489121 | PFSK-1 | brain: | n/a |
39 | chr17:20489071-20489121 | HCF | heart: | n/a |
40 | chr17:20489071-20489121 | A549 | lung: | n/a |
41 | chr17:20489071-20489121 | Jurkat | blood: | n/a |
42 | chr17:20489071-20489121 | GM19239 | blood: | n/a |
43 | chr17:20489071-20489121 | HRPEpiC | eye: | n/a |
44 | chr17:20489071-20489121 | AG09309 | skin: | n/a |
45 | chr17:20489071-20489121 | HEK293 | kidney: | embryo |
46 | chr17:20489071-20489121 | ECC-1 | luminal epithelium: | n/a |
47 | chr17:20489071-20489121 | U87 | brain: | n/a |
48 | chr17:20489071-20489121 | HRCEpiC | kidney: | n/a |
49 | chr17:20489071-20489121 | GM12892 | blood: | n/a |
50 | chr17:20489071-20489121 | BE2_C | brain: | n/a |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
MEIS3P2 | TF binding region |
MEIS3P2 | CpG island |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs530616230 | chr17:20487972-20487973 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs550930741 | chr17:20487974-20487975 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs147181078 | chr17:20487975-20487976 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs201373331 | chr17:20488022-20488023 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs76850913 | chr17:20488023-20488024 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs56834160 | chr17:20488024-20488025 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs529125438 | chr17:20488155-20488156 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs547681148 | chr17:20488181-20488182 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs185333507 | chr17:20488197-20488198 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs377475353 | chr17:20488213-20488214 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs533129311 | chr17:20488218-20488219 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs189752374 | chr17:20488242-20488243 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs140635868 | chr17:20488349-20488350 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs537176008 | chr17:20488354-20488355 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs555462900 | chr17:20488430-20488431 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs375268711 | chr17:20488466-20488467 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs180684749 | chr17:20488488-20488489 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs58220184 | chr17:20488489-20488490 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs553202790 | chr17:20488544-20488545 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs578227857 | chr17:20488561-20488562 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs147843904 | chr17:20488635-20488636 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs139063415 | chr17:20488636-20488637 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs186449054 | chr17:20488651-20488652 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs543517878 | chr17:20488657-20488658 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs561784506 | chr17:20488681-20488682 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs529060217 | chr17:20488706-20488707 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs538678161 | chr17:20488731-20488732 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs541231180 | chr17:20488736-20488737 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs397832415 | chr17:20488755-20488756 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs397832414 | chr17:20488762-20488763 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs192260079 | chr17:20488787-20488788 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs58117074 | chr17:20488788-20488789 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs397954330 | chr17:20488791-20488792 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs369611313 | chr17:20488841-20488842 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs659542 | chr17:20488843-20488844 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs77150062 | chr17:20488844-20488845 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs116342414 | chr17:20488849-20488850 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs149875309 | chr17:20488943-20488944 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs530827414 | chr17:20488988-20488989 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs549023961 | chr17:20489000-20489001 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs658678 | chr17:20489028-20489029 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs658645 | chr17:20489056-20489057 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs547209034 | chr17:20489072-20489073 | Weak transcription | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs149046660 | chr17:20489079-20489080 | Weak transcription | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs539349455 | chr17:20489104-20489105 | Weak transcription | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs557392760 | chr17:20489121-20489122 | Weak transcription | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs576074923 | chr17:20489170-20489171 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs537055117 | chr17:20489177-20489178 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs183583627 | chr17:20489203-20489204 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs376525965 | chr17:20489217-20489218 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 16608533 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Chordoma | 21602918 | CNVD |
Miller-Dieker syndrome | 22283845 | CNVD |
Non-syndromic sensorineural hearing loss | 17457615 | CNVD |
Cancer | 22429812 | CNVD |
Chronic lymphocytic leukemia | 21795749 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Paraganglioma | 21461997 | CNVD |
Pheochromocytoma | 21461997 | CNVD |
Breast cancer | 22028636 | CNVD |
Breast cancer | 20837533 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
colon cancer | 17210682 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Cancer | 16751803 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Chronic lymphocytic leukemia | 17971485 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Breast cancer | 16461572 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Breast cancer | 17133270 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Moyamoya disease | 22323933 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute myeloid leukemia | 20724749 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
Colorectal cancer | 21645411 | CNVD |
HIV/AIDS | 22844521 | CNVD |
Psoriasis | 22844521 | CNVD |
Rheumatoid arthritis | 22844521 | CNVD |
Sclerosis systemic | 22844521 | CNVD |
Systemic lupus erythematosus | 22844521 | CNVD |
HIV/AIDS | 17953491 | CNVD |
HIV/AIDS | 20877625 | CNVD |
Immune disease | 21076436 | CNVD |
Rheumatoid arthritis | 17953491 | CNVD |
Type 1 diabetes | 17953491 | CNVD |
HIV/AIDS | 15637236 | CNVD |
Prostate cancer | 18632612 | CNVD |
Lung cancer | 18438408 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Neurofibromatosis | 18196300 | CNVD |
Breast cancer | 17001317 | CNVD |
Rhabdomyosarcoma | 16790082 | CNVD |
Charcot-marie-tooth disease | 16463004 | CNVD |
Osteosarcoma | 22292074 | CNVD |
Breast cancer | 17603634 | CNVD |
Charcot | 16760730 | CNVD |
Mental retardation | 17901693 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
ovarian endometriomas | 16273235 | CNVD |
Smith-Magenis syndrome | 18923513 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 16272173 | CNVD |
Austim spectrum disorder | 21302340 | CNVD |
Autism | 22492990 | CNVD |
Congenital abnormalities | 21549014 | CNVD |
Developmental delay | 18414209 | CNVD |
Developmental delay | 21549014 | CNVD |
Epilepsy | 20970697 | CNVD |
Mental retardation | 18414209 | CNVD |
Mental retardation | 21549014 | CNVD |
Smith-Magenis syndrome | 21981782 | CNVD |
Smith-Magenis syndrome | 20188345 | CNVD |
Smith-Magenis syndrome | 16775514 | CNVD |
Smith-Magenis syndrome | 22585170 | CNVD |
Smith-Magenis syndrome | 22241247 | CNVD |
Autism | 20970697 | CNVD |
Mental retardation | 19951919 | CNVD |
Potocki-Lupski syndrome | 21271655 | CNVD |
Potocki-lupski syndrome | 17357070 | CNVD |
Potocki-lupski syndrome | 20110824 | CNVD |
Potocki-lupski syndrome | 18923514 | CNVD |
Potocki-lupski syndrome | 22241247 | CNVD |
Potocki-lupski syndrome | 20188345 | CNVD |
Schizophrenia | 21399695 | CNVD |
Mental retardation | 16773131 | CNVD |
Adenocarcinoma | 19607727 | CNVD |
Squamous cell cancer | 19607727 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Charcot-marie-tooth disease | 22470819 | CNVD |
Neurofibromatosis | 22470819 | CNVD |
Neuropathy | 22470819 | CNVD |
Smith-Magenis syndrome | 18301319 | CNVD |
Smith-Magenis syndrome | 17357070 | CNVD |
Smith-Magenis syndrome | 18469339 | CNVD |
Smith-Magenis syndrome | 22241097 | CNVD |
Smith-Magenis syndrome | 22470819 | CNVD |
Tourette syndrome | 18923514 | CNVD |
Type 1 diabetes | 22470819 | CNVD |
Potocki-lupski syndrome | 18469339 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Neuropathy | 17597781 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Neurodevelopmental disorder | 17015230 | CNVD |
Smith-Magenis syndrome | 17597781 | CNVD |
Potocki-lupski syndrome | 18059269 | CNVD |
Potocki-lupski syndrome | 17597781 | CNVD |
Mental retardation | 17847001 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Breast cancer | 20409316 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Breast cancer | 21509527 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr17:20472800-20492200 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
2 | chr17:20484800-20492200 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |